Robert V. O’Toole

10.3k total citations · 1 hit paper
282 papers, 6.4k citations indexed

About

Robert V. O’Toole is a scholar working on Surgery, Epidemiology and Emergency Medicine. According to data from OpenAlex, Robert V. O’Toole has authored 282 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Surgery, 113 papers in Epidemiology and 54 papers in Emergency Medicine. Recurrent topics in Robert V. O’Toole's work include Bone fractures and treatments (107 papers), Hip and Femur Fractures (94 papers) and Pelvic and Acetabular Injuries (69 papers). Robert V. O’Toole is often cited by papers focused on Bone fractures and treatments (107 papers), Hip and Femur Fractures (94 papers) and Pelvic and Acetabular Injuries (69 papers). Robert V. O’Toole collaborates with scholars based in United States, Canada and Netherlands. Robert V. O’Toole's co-authors include Jason W. Nascone, Marcus F. Sciadini, Theodore T. Manson, Renan C. Castillo, David S. Alberts, Edward V. Hannigan, Ernest W. Franklin, Vinay K. Malviya, P. Y. Liu and Mark Adelson and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Robert V. O’Toole

265 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

1996 906 citations David S. Alberts, P. Y. Liu et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robert V. O’Toole	4.7k	1.6k	1.1k	849	686	282	6.4k
Dirk Stengel	3.4k 0.7×	976 0.6×	316 0.3×	606 0.7×	298 0.4×	176	4.5k
Elizabeth Benjamin	1.4k 0.3×	528 0.3×	402 0.4×	1.0k 1.2×	419 0.6×	198	3.6k
Paul S. Sidhu	3.5k 0.7×	1.6k 1.0×	628 0.6×	273 0.3×	287 0.4×	305	8.4k
Luca Ansaloni	5.5k 1.2×	389 0.2×	524 0.5×	2.1k 2.5×	222 0.3×	299	7.6k
İbrahim Alkatout	1.3k 0.3×	429 0.3×	1.0k 0.9×	98 0.1×	485 0.7×	269	3.8k
Mikael Hellström	1.4k 0.3×	951 0.6×	360 0.3×	71 0.1×	366 0.5×	155	4.9k
Simon W. Nienhuijs	4.3k 0.9×	216 0.1×	538 0.5×	1.2k 1.5×	128 0.2×	209	5.1k
Laman A. Gray	1.6k 0.3×	423 0.3×	247 0.2×	472 0.6×	96 0.1×	128	3.0k
Jeffrey Barkun	9.7k 2.1×	1.2k 0.8×	350 0.3×	928 1.1×	737 1.1×	102	14.0k
Stewart R. Walsh	3.5k 0.8×	625 0.4×	142 0.1×	809 1.0×	185 0.3×	231	7.6k

Countries citing papers authored by Robert V. O’Toole

Since Specialization

Citations

This map shows the geographic impact of Robert V. O’Toole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert V. O’Toole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert V. O’Toole more than expected).

Fields of papers citing papers by Robert V. O’Toole

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert V. O’Toole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert V. O’Toole. The network helps show where Robert V. O’Toole may publish in the future.

Co-authorship network of co-authors of Robert V. O’Toole

This figure shows the co-authorship network connecting the top 25 collaborators of Robert V. O’Toole. A scholar is included among the top collaborators of Robert V. O’Toole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert V. O’Toole. Robert V. O’Toole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Carol A., Nathan N. O’Hara, Robert V. O’Toole, et al.. (2025). Outcomes Associated with Choice of Prophylactic Antibiotics in Open Fractures. PubMed. 107(Suppl 1). 19–27.

Brodke, Dane J., Gregory R. Hancock, Haley K. Demyanovich, et al.. (2025). Predicting Post-Fracture Recovery with Smartphone Mobility Data. Journal of Bone and Joint Surgery. 107(11). e57–e57.

Johnson, Daniel J., Nathan N. O’Hara, Lisa Reider, et al.. (2024). Risk factors for infection in severe open tibial shaft fractures. Injury. 55(11). 111822–111822. 2 indexed citations

O’Connor, Katherine, et al.. (2023). A deep surgical site infection risk score for patients with open tibial shaft fractures treated with intramedullary nail. Injury. 54(10). 110965–110965. 6 indexed citations

O’Hara, Nathan N., et al.. (2023). The Use of Vancomycin Powder in Tibial Plateau Fractures at Lower Risk of Infection. Journal of Orthopaedic Trauma. 37(6). 282–286.

Marchand, Lucas S., Haley K. Demyanovich, Katherine O’Connor, et al.. (2023). Patient preferences for physical therapy programs after a lower extremity fracture: a discrete choice experiment. BMJ Open. 13(10). e072583–e072583. 5 indexed citations

Shannon, Steven F., et al.. (2022). Outcomes of Tibiotalocalcaneal Hindfoot Fusion Nails Used for Acute Lower Extremity Trauma in a High-Risk Patient Population. Journal of Orthopaedic Trauma. 37(1). e7–e12. 2 indexed citations

O’Hara, Nathan N., Renan C. Castillo, Anthony R. Carlini, et al.. (2022). Application of Bayesian Methods to Help Interpret the VANCO Trial Results. Journal of Orthopaedic Trauma. 37(1). 1–7. 6 indexed citations

Lin, Carol A., Nathan N. O’Hara, Sheila Sprague, et al.. (2021). Low Adherence to Recommended Guidelines for Open Fracture Antibiotic Prophylaxis. Journal of Bone and Joint Surgery. 103(7). 609–617. 19 indexed citations

10.

DuBose, Joseph J., Clay Cothren Burlew, Bellal Joseph, et al.. (2021). Pelvic fracture-related hypotension: A review of contemporary adjuncts for hemorrhage control. The Journal of Trauma: Injury, Infection, and Critical Care. 91(4). e93–e103. 9 indexed citations

11.

O’Hara, Lyndsay M., Nathan N. O’Hara, Robert V. O’Toole, et al.. (2019). What publicly available quality metrics do hip and knee arthroplasty patients care about most when selecting a hospital in Maryland: a discrete choice experiment. BMJ Open. 9(5). e028202–e028202. 10 indexed citations

12.

O’Hara, Nathan N., David T. Wells, C. Daniel Mullins, et al.. (2019). Which orthopaedic trauma patients are likely to refuse to participate in a clinical trial? A latent class analysis. BMJ Open. 9(10). e032631–e032631. 2 indexed citations

13.

Rothrock, Nan, Michael Bass, Andrea Blumenthal, et al.. (2018). AO Patient Outcomes Center: Design, Implementation, and Evaluation of a Software Application for the Collection of Patient-Reported Outcome Measures in Orthopedic Outpatient Clinics. JMIR Formative Research. 3(2). e10880–e10880. 9 indexed citations

14.

Dreizin, David, Uttam K. Bodanapally, Alexis R. Boscak, et al.. (2018). CT Prediction Model for Major Arterial Injury after Blunt Pelvic Ring Disruption. Radiology. 287(3). 1061–1069. 29 indexed citations

15.

Haac, Bryce E., Nathan N. O’Hara, C. Daniel Mullins, et al.. (2017). Patient preferences for venous thromboembolism prophylaxis after injury: a discrete choice experiment. BMJ Open. 7(8). e016676–e016676. 22 indexed citations

16.

Shiber, Joseph, Shreyas Roy, Benjamin Sadowitz, et al.. (2013). Early application of airway pressure release ventilation may reduce mortality in high-risk trauma patients. The Journal of Trauma: Injury, Infection, and Critical Care. 75(4). 635–641. 76 indexed citations

17.

Malviya, Vinay K., P. Y. Liu, Robert V. O’Toole, et al.. (1994). Phase II Trial of Amonafide in Patients with Advanced Metastatic or Recurrent Endometrial Adenocarcinoma A Southwest Oncology Group Study. American Journal of Clinical Oncology. 17(1). 37–40. 9 indexed citations

18.

Alberts, D S, Edward V. Hannigan, Renzo Canetta, et al.. (1994). Cisplatin versus carboplatin in advanced ovarian cancer: An economic analysis. 19(7). 3 indexed citations

19.

Homesley, Howard D., Irving Shemano, Richard A. Gams, et al.. (1993). Antiestrogenic Potency of Toremifene and Tamoxifen in Postmenopausal Women. American Journal of Clinical Oncology. 16(2). 117–122. 25 indexed citations

20.

Homesley, Howard D., Robert V. O’Toole, Barth Hoogstraten, et al.. (1992). Randomized Comparison of Cisplatin plus Epirubicin or Doxorubicin for Advanced Epithelial Ovarian Carcinoma. American Journal of Clinical Oncology. 15(2). 129–134. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact